ScholarIQanswers from OpenAlex

Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells

PaperCitations, authors & open-access status

Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells have?

ScholarIQcitation count

Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells has 33 citations in the OpenAlex counts ScholarIQ stores.

When was Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells published?

ScholarIQyear

Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells has 2017 year in the ScholarIQ index.

What is the open-access status of Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells?

ScholarIQoa status

Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells has diamond oa status in the ScholarIQ index.

What is the DOI of Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells?

ScholarIQdoi

The DOI for Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells is on the source record.

What is the PMID of Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells?

ScholarIQpmid

The PMID for Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells is on the source record.

What is the OpenAlex record for Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells?

ScholarIQopenalex

The OpenAlex for Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial